|
Christofer "Chris" Toumazou, FRS, FREng, FMedSci, FIET, FIEEE, FCGI, FRSM, CEng ((ギリシア語:Χριστόφορος Τουμάζου), born 5 July 1961) is a British Cypriot electronic engineer. In 2013 he became London’s first Regius Professor of Engineering conferred to Imperial College London during the Queen’s Diamond Jubilee. Toumazou is also Chief Scientist of the Institute of Biomedical Engineering and Professor of Circuit Design at Imperial; founder of Toumaz Holdings Ltd, chairman and founder of DNA Electronics Ltd. and Chief Scientific Advisor to GENEU. He has been involved in developing new technologies, mainly in medical field, creating a research institute and a number of commercial ventures to commercialize his research. In particular Toumazou invented and licensed Portable and Rapid Semiconductor Genome Sequencing which has now become a multibillion-dollar industry. One of his motivators was the diagnosis of his 13-year-old son with end stage kidney failure through a rare genetic mutation.〔(【引用サイトリンク】url=http://edition.cnn.com/video/data/2.0/video/bestoftv/2014/06/12/spc-make-create-innovate-genalysis.cnn.html )〕 He has published over 750 research papers and holds 50 patents in the field of semiconductors and healthcare. Toumazou's career began with the invention and development of entirely novel concept of current-mode analogue circuitry for ultra-low-power electronic devices. He has worked on applying silicon chip technology to biomedical and life-science applications, most recently to DNA analysis. Amongst his key inventions was that of semiconductor based DNA sequencing. For his inventions on semiconductor based genetic testing he won the Gabor Medal of the Royal Society (2013) and European Inventor Award (2014). He is the first British winner of the prize in this contest since 2008. ==Biography== 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Chris Toumazou」の詳細全文を読む スポンサード リンク
|